Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications. Highlights
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsBcl-2-like protein 1 (BCL2L1), encoded by the BCL2L1 gene, belongs to the BCL-2 protein family. BCL-2 family members form heterozygous or homologous dimers and participate in various cell activities as anti-apoptotic or pro-apoptotic regulators. BCL2L1 is expressed at the outer mitochondrial membrane, involved the regulation of mitochondrial membrane potential, controlling the production of reactive oxygen species and release of cytochrome C by mitochondria.
| Basic Information of BCL2L1 | |
| Protein Name | Bcl-2-like protein 1 |
| Gene Name | BCL2L1 |
| Aliases | Bcl2-L-1, Apoptosis regulator Bcl-X, BCL2L, BCLX |
| Organism | Homo sapiens (Human) |
| UniProt ID | Q07817 |
| Transmembrane Times | 0 |
| Length (aa) | 233 |
| Sequence | MSQSNRELVVDFLSYKLSQKGYSWSQFSDVEENRTEAPEGTESEMETPSAINGNPSWHLADSPAVNGATGHSSSLDAREVIPMAAVKQALREAGDEFELRYRRAFSDLTSQLHITPGTAYQSFEQVVNELFRDGVNWGRIVAFFSFGGALCVESVDKEMQVLVSRIAAWMATYLNDHLEPWIQENGGWDTFVELYGNNAAAESRKGQERFNRWFLTGMTVAGVVLLGSLFSRK |
BCL2-family proteins have been revealed to regulate programmed cell death or apoptosis. Some members of the family (e.g. Bcl-2, Bcl-XL, and Mcl-1) display antiapoptotic functions, while others (e.g. Bax, Bak, and Bok ) exhibit proapoptotic effects. Located at the outer mitochondrial membrane, BCL2L1 controls the generation of reactive oxygen species and release of cytochrome C, which is associated with cell apoptosis. It has been reported BCL2L1 inhibits cell death and seems to regulate cell death through blocking the voltage-dependent anion channel (VDAC) and preventing the release of the caspase activator, CYC1, from the mitochondrial membrane. Besides, BCL2L1 also functions as a regulator of G2 checkpoint and progression to cytokinesis during mitosis.
Fig.1 Bcl-2-like protein 1 structure.
Rno-miR-665 can affect isophenols by counteracting the negative localization of apoptotic BCL2L1, so it can be a potential target for children's anesthesia.
This study suggested the poor response to drug therapy by targeting BCL2L1 may be associated with up-regulated miR-184 in osteosarcoma patients.
Authors in this study indicated that BCL2L1 and DLC1 may be regarded as potential druggable targets for specific subsets of gastric cancer cases.
The investigation implicated that the BCL2L1-PGAM5-FUNDC1 axis is involved in receptor-mediated mitophagy in response to hypoxia.
The study indicated that BCL2L1 is not likely to be a driver of chromosome 20q gain associated adenoma-to-carcinoma progression.
To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-BCL2L1 antibody development services.
Creative Biolabs' skillful scientists are glad to leverage our expertise and advanced technologies to help you with the member protein research. If you are interested, please feel free to contact us for more details.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
